OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

CRH PLC/  IE0001827041  /

Turquoise
2023-09-08  5:27:59 PM Chg. -0.02 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
50.92EUR -0.04% 248,416
Turnover: 12.6 mill.		 -Bid Size: - -Ask Size: - 53.29 bill.EUR - -
GlobeNewswire 04-09 Emerging Markets Report: Follow the Leader
GlobeNewswire 03-28 Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update
GlobeNewswire 03-26 Aptose Reports Results for the Fourth Quarter and Full Year 2023
GlobeNewswire 03-14 HEALWELL AI Announces New Commercial Agreements with WELL HEALTH USA and Circle Medical, Bringing AI...
GlobeNewswire 02-27 Kura Oncology Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire 02-26 ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31, 2023
GlobeNewswire 02-12 Martin Marietta Announces Acquisition of Aggregates Operations From Affiliates of Blue Water Industr...
GlobeNewswire 01-30 Kura Oncology Reports Positive Preliminary Ziftomenib Combination Data in Acute Myeloid Leukemia
GlobeNewswire 2023-12-18 Kronos Bio Announces Pipeline Update and p300 KAT Inhibitor Development Candidate
GlobeNewswire 2023-12-11 Sutro Biopharma Announces New Positive Data from the Compassionate Use of Luveltamab Tazevibulin (lu...
GlobeNewswire 2023-12-11 Cogent Biosciences Announces Positive Data from Ongoing Phase 2 APEX Trial Evaluating Bezuclastinib ...
GlobeNewswire 2023-11-21 Martin Marietta to Divest South Texas Cement and Related Concrete Operations to CRH plc
GlobeNewswire 2023-11-14 Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire 2023-11-09 Aptose Reports Results for the Third Quarter 2023
GlobeNewswire 2023-11-02 Kura Oncology Reports Third Quarter 2023 Financial Results
GlobeNewswire 2023-10-30 Aptose Presents Highlights from Clinical Update Webcast Featuring Latest Available Data on AML Drug ...
GlobeNewswire 2023-10-27 ORYZON Reports Financial Results and Corporate Updates for Quarter Ended September 30, 2023
GlobeNewswire 2023-10-23 Aptose to Hold Clinical Update and KOL Data Review of AML Drug Tuspetinib on Monday, October 30th
GlobeNewswire 2023-10-16 Aptose Clinical and Preclinical Data to be Presented at European School of Haematology (ESH) 6th Int...
TeleTrader 2023-10-12 Europe opens higher amid economic data, US inflation report
GlobeNewswire 2023-09-18 Aptose to Present at the Cantor Global Healthcare Conference
GlobeNewswire 2023-09-11 Media Advisory: Gary White and Matt Damon to join CEOs and global leaders at UN Global Compact Leade...
Newsfile Corp 2023-08-29 Teako Minerals Announces Changes to Board of Directors
TeleTrader 2023-08-25 Europe closes higher after data, Powell's speech
GlobeNewswire 2023-08-24 Aptose to Present at the H.C. Wainwright 25th Annual Global Investment Conference